BioCentury
ARTICLE | Clinical News

Zerviate regulatory update

March 10, 2017 8:09 PM UTC

Nicox resubmitted an NDA to FDA for Zerviate cetirizine to treat ocular itching associated with allergic conjunctivitis. Last year, FDA issued a complete response letter to Nicox for the product due ...

BCIQ Company Profiles

Nicox S.A.

BCIQ Target Profiles

Histamine H1 receptor (HRH1)